As weight drops fast, cosmetic clinics see surge in ‘Ozempic face’ fixes
With the GLP-1 drug market expanding after the patent expiry of semaglutide in India, doctors expect demand to grow exponentially, and caution that unchecked use of the drugs could lead to higher numbers.
Original Source
Read the full article at Livemint →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.